Edition:
United States

OraSure Technologies Inc (OSUR.OQ)

OSUR.OQ on NASDAQ Stock Exchange Global Select Market

20.24USD
20 Oct 2017
Change (% chg)

$0.66 (+3.37%)
Prev Close
$19.58
Open
$19.75
Day's High
$20.24
Day's Low
$19.75
Volume
276,573
Avg. Vol
228,932
52-wk High
$23.00
52-wk Low
$7.09

Chart for

About

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $1,203.46
Shares Outstanding(Mil.): 59.46
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 33.06 16.52
EPS (TTM): -- -- --
ROI: -- 13.87 11.32
ROE: -- 16.68 15.18

BRIEF-Orasure Q2 earnings per share $0.09

* Q2 earnings per share view $0.07 -- Thomson Reuters I/B/E/S

Aug 02 2017

BRIEF-Orasure's OraQuick HIV Self-Test selected for next phase of STAR Project in Africa

* OraSure Technologies Inc - OraQuick HIV self-test (hivst) has been selected by UnitAid and Population Services International

Jul 24 2017

BRIEF-Orasure Technologies reports agreement with Bill & Melinda Gates Foundation

* Orasure Technologies - announced agreement with Bill & Melinda Gates Foundation,will enable co to offer or a quick HIV self-test at an affordable price

Jun 27 2017

BRIEF-OraSure Tech appoints Mara Aspinall to board of directors

* OraSure Technologies appoints Mara G. Aspinall to board of directors

Jun 22 2017

BRIEF-Orasure announces Q1 revenue $32.5 million

* Q1 earnings per share view $0.18 -- Thomson Reuters I/B/E/S

May 03 2017

BRIEF-Grifols says restated its 2005 agreement with Orasure Technologies

* Grifols - announces that it has restated its 2005 agreement with Orasure Technologies

Apr 24 2017

Earnings vs. Estimates